4.4 (0.83%)
4.4 (0.83%) 5.48 pm | 10 May 2012 | Source: CNBC-TV18
Higher tax expenses led to a decline in consolidated net profit of pharma company, Lupin in the fourth quarter of FY12. The company posted a decline o...
3.46 pm | 10 May 2012 | Source: Moneycontrol.com
Pharma company Lupin's fourth quarter consolidated net profit declined 31% year-on-year to Rs 156 crore due to higher tax expenses....
9.39 am | 10 May 2012 | Source: CNBC-TV18
Pharmaceutical company Lupin is expected to report a growth of 17.9% year-on-year and 14% quarter-on-quarter in its profit after tax of Rs 267 crore f...